iFAST Diagnostics bags £5M to speed up infection testing and tackle antimicrobial resistance
iFAST Diagnostics bags £5M to speed up infection testing and tackle antimicrobial resistance UK biotech iFAST Diagnostics has closed a £5 million funding round. iFAST is addressing the $4 billion (and growing) Antimicrobial Susceptibility Testing (AST) market. It has developed a test delivering results in under three hours from a
